3 October 2019 ORYZON Presents New Positive REIMAGINE Efficacy Data of Vafidemstat in the Treatment of Aggression
30 September 2019 ORYZON presents positive efficacy results on iadademstat in ED-SCLC patients at ESMO-2019
10 September 2019 ORYZON presents new positive efficacy data on vafidemstat for treatment of aggression
30 July 2019 ORYZON Reports Financial Results and Corporate Update for the First Half Ended June 30, 2019
29 July 2019 ORYZON Announces End of Patient Recruitment for its Phase IIa trials in aggression with vafidemstat: REIMAGINE and REIMAGINE-AD